Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Finocchiaro

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 22, 2025
Long-term outcomes of percutaneous coronary intervention for recurrent events in patients undergoing target-vessel vs. nontarget-vessel revascularizationSimone Finocchiaro, Maria Sara Mauro, Claudio Laudani, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 18, 2025
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysisMarco Spagnolo, Claudio Laudani, Antonino Imbesi, et al.
European Heart Journal|June 5, 2026
P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisMarco Spagnolo, Antonino Imbesi, Costanza Agata Bordonaro, et al.
Circulation|March 13, 2023
Pharmacology and Clinical Development of Factor XI InhibitorsAntonio Greco, Claudio Laudani, Marco Spagnolo, et al.
Thrombosis and Haemostasis|January 27, 2025
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCIMarco Spagnolo, Nicola Ammirabile, Luigi Cutore, et al.
Expert Review of Cardiovascular Therapy|November 23, 2023
PCSK9 inhibitors: current status and emerging frontiers in lipid controlFederica Agnello, Maria Sara Mauro, Carla Rochira, et al.
Revista Espanola De Cardiologia (English Ed.)|October 17, 2023
Association of trial characteristics with simultaneous publication and its impact on citations and mentions: a cross-sectional studyMarco Spagnolo, Antonio Greco, Claudio Laudani, et al.
Circulation|February 10, 2025
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and ProspectsAntonio Greco, Simone Finocchiaro, Marco Spagnolo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Percutaneous interventions for pulmonary embolismSimone Finocchiaro, Maria Sara Mauro, Carla Rochira, et al.
JACC. Cardiovascular Interventions|October 11, 2023
Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A Systematic ReviewDenise Cristiana Faro, Claudio Laudani, Federica Giuseppa Agnello, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 22, 2025
Long-term outcomes of percutaneous coronary intervention for recurrent events in patients undergoing target-vessel vs. nontarget-vessel revascularizationSimone Finocchiaro, Maria Sara Mauro, Claudio Laudani, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 18, 2025
Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysisMarco Spagnolo, Claudio Laudani, Antonino Imbesi, et al.
European Heart Journal|June 5, 2026
P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisMarco Spagnolo, Antonino Imbesi, Costanza Agata Bordonaro, et al.
Circulation|March 13, 2023
Pharmacology and Clinical Development of Factor XI InhibitorsAntonio Greco, Claudio Laudani, Marco Spagnolo, et al.
Thrombosis and Haemostasis|January 27, 2025
Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCIMarco Spagnolo, Nicola Ammirabile, Luigi Cutore, et al.
Expert Review of Cardiovascular Therapy|November 23, 2023
PCSK9 inhibitors: current status and emerging frontiers in lipid controlFederica Agnello, Maria Sara Mauro, Carla Rochira, et al.
Revista Espanola De Cardiologia (English Ed.)|October 17, 2023
Association of trial characteristics with simultaneous publication and its impact on citations and mentions: a cross-sectional studyMarco Spagnolo, Antonio Greco, Claudio Laudani, et al.
Circulation|February 10, 2025
Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and ProspectsAntonio Greco, Simone Finocchiaro, Marco Spagnolo, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Percutaneous interventions for pulmonary embolismSimone Finocchiaro, Maria Sara Mauro, Carla Rochira, et al.
JACC. Cardiovascular Interventions|October 11, 2023
Complete Percutaneous Coronary Revascularization in Acute Coronary Syndromes With Multivessel Coronary Disease: A Systematic ReviewDenise Cristiana Faro, Claudio Laudani, Federica Giuseppa Agnello, et al.
Pageof 3